Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Celyad Oncology (CYAD)

Celyad Oncology SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:CYAD
DateTimeSourceHeadlineSymbolCompany
08/02/202421:01GlobeNewswire Inc.Celyad Oncology announces intention to terminate SEC reporting obligationsEU:CYADCelyad Oncology SA
16/01/202421:01GlobeNewswire Inc.Celyad Oncology provides fourth quarter 2023 business update and 2024 outlookEU:CYADCelyad Oncology SA
20/12/202321:01GlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
15/12/202321:01GlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
04/12/202321:01GlobeNewswire Inc.Celyad announces management changeEU:CYADCelyad Oncology SA
01/12/202311:42GlobeNewswire Inc.Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
21/11/202321:00GlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
14/11/202321:00GlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
09/11/202306:00GlobeNewswire Inc.Celyad Oncology reports third quarter 2023 financial results and recent business highlightsEU:CYADCelyad Oncology SA
25/09/202321:01GlobeNewswire Inc.Celyad Oncology announces the termination of its American Depository Receipt programEU:CYADCelyad Oncology SA
15/09/202321:01GlobeNewswire Inc.Publication of a rectified transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
12/09/202321:01GlobeNewswire Inc.Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
07/09/202321:01GlobeNewswire Inc.Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
05/09/202321:00GlobeNewswire Inc.Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)EU:CYADCelyad Oncology SA
04/09/202321:00GlobeNewswire Inc.Celyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsEU:CYADCelyad Oncology SA
24/08/202321:00GlobeNewswire Inc.Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholdersEU:CYADCelyad Oncology SA
15/05/202321:01GlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq delisting noticeEU:CYADCelyad Oncology SA
05/05/202306:00GlobeNewswire Inc.Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From NasdaqEU:CYADCelyad Oncology SA
05/05/202306:00GlobeNewswire Inc.Celyad Oncology reports first quarter 2023 financial results and recent business highlightsEU:CYADCelyad Oncology SA
24/04/202321:01GlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid priceEU:CYADCelyad Oncology SA
04/04/202321:01GlobeNewswire Inc.Celyad Oncology announces receipt of Nasdaq noticeEU:CYADCelyad Oncology SA
24/03/202306:00GlobeNewswire Inc.Celyad Oncology appoints Georges Rawadi as its new CEOEU:CYADCelyad Oncology SA
23/03/202321:01GlobeNewswire Inc.Celyad Oncology reports full year 2022 financial results and recent business highlightsEU:CYADCelyad Oncology SA
17/03/202321:01GlobeNewswire Inc.Celyad Oncology to announce full year 2022 financial results and host conference callEU:CYADCelyad Oncology SA
15/03/202306:00GlobeNewswire Inc.Celyad Oncology announces non-cash impairmentEU:CYADCelyad Oncology SA
01/03/202306:00GlobeNewswire Inc.REPEAT -- Celyad Oncology SA - Letter to ShareholdersEU:CYADCelyad Oncology SA
28/02/202316:16GlobeNewswire Inc.Celyad Oncology SA - Letter to ShareholdersEU:CYADCelyad Oncology SA
09/02/202306:00GlobeNewswire Inc.Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01EU:CYADCelyad Oncology SA
03/02/202306:00GlobeNewswire Inc.Celyad Oncology provides fourth quarter 2022 business update and 2023 outlookEU:CYADCelyad Oncology SA
21/12/202206:00GlobeNewswire Inc.Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual propertyEU:CYADCelyad Oncology SA
 Showing the most relevant articles for your search:EU:CYAD